Target enzymes in serine-glycine-one-carbon metabolic pathway for cancer therapy

Area of Science:

• Metabolic pathways in oncology
• Cancer cell metabolism
• Biochemical pathways in tumorigenesis

Background:

• Cancer cells exhibit altered metabolism, relying on specific pathways for growth and survival.
• Serine-glycine-one-carbon (SGOC) metabolism is crucial for nucleotide biosynthesis in tumors.
• Enzymes within the SGOC pathway are implicated in cancer progression, metastasis, and therapeutic resistance.

Purpose of the Study:

• To review the role of serine and glycine in the folate-mediated one-carbon pathway during cancer progression.
• To highlight mechanisms of one-carbon unit acquisition and utilization by cancer cells.
• To discuss the impact of SGOC metabolic enzymes on tumor development and drug resistance.

Main Methods:

• Literature review focusing on serine-glycine-one-carbon metabolism in cancer.
• Analysis of the folate cycle and its role in nucleotide biosynthesis.
• Examination of evidence linking SGOC enzymes to tumorigenesis and therapy resistance.

Main Results:

• Cancer cells depend on exogenous serine or de novo serine synthesis for nucleotide production.
• The SGOC pathway provides essential one-carbon units for cancer cell proliferation.
• Metabolic enzymes in the SGOC pathway are critical regulators of tumor growth and metastasis.
• Dysregulation of SGOC metabolism contributes to resistance against cancer therapies.

Conclusions:

• The serine-glycine-one-carbon metabolic network is a key driver of tumorigenesis.
• Targeting enzymes within the SGOC pathway presents a viable therapeutic strategy for cancer.
• Inhibitors of SGOC pathway enzymes show potential as novel anti-cancer drug candidates.